ALPS Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-101,422
| Closed | -$3.99M | – | 1162 |
|
|
2023
Q2 | $3.99M | Buy |
101,422
+11,084
| +12% | +$391K | 0.03% | 210 |
|
|
2023
Q1 | $2.2M | Sell |
90,338
-502
| -0.6% | -$11K | 0.02% | 269 |
|
|
2022
Q4 | $1.94M | Buy |
90,840
+26,345
| +41% | +$562K | 0.02% | 303 |
|
|
2022
Q3 | $1.16M | Sell |
64,495
-4,562
| -7% | -$59.9K | 0.01% | 425 |
|
|
2022
Q2 | $664K | Sell |
69,057
-49,812
| -42% | -$625K | 0.01% | 533 |
|
|
2022
Q1 | $2M | Sell |
118,869
-13,806
| -10% | -$204K | 0.02% | 209 |
|
|
2021
Q4 | $2.22M | Buy |
132,675
+5,199
| +4% | +$85.2K | 0.03% | 280 |
|
|
2021
Q3 | $2.07M | Buy |
127,476
+8,598
| +7% | +$93.6K | 0.02% | 313 |
|
|
2021
Q2 | $750K | Sell |
118,878
-44,211
| -27% | -$285K | 0.01% | 453 |
|
|
2021
Q1 | $1.01M | Buy |
163,089
+1,315
| +0.8% | +$7.98K | 0.01% | 398 |
|
|
2020
Q4 | $1.12M | Buy |
161,774
+47,635
| +42% | +$305K | 0.01% | 378 |
|
|
2020
Q3 | $644K | Buy |
114,139
+45,588
| +67% | +$217K | 0.01% | 398 |
|
|
2020
Q2 | $350K | Buy |
+68,551
| New | +$286K | ﹤0.01% | 518 |
|
|
2017
Q2 | – | Sell |
-30,711
| Closed | -$112K | – | 791 |
|
|
2017
Q1 | $112K | Sell |
30,711
-3,596
| -10% | -$15.2K | ﹤0.01% | 718 |
|
|
2016
Q4 | $166K | Sell |
34,307
-11,067
| -24% | -$329K | ﹤0.01% | 701 |
|
|
2016
Q3 | $2.09M | Sell |
45,374
-4,315
| -9% | -$243K | 0.02% | 181 |
|
|
2016
Q2 | $2.54M | Buy |
49,689
+10,373
| +26% | +$515K | 0.02% | 157 |
|
|
2016
Q1 | $1.66M | Sell |
39,316
-6,738
| -15% | -$343K | 0.02% | 162 |
|
|
2015
Q4 | $3.62M | Sell |
46,054
-7,630
| -14% | -$441K | 0.04% | 140 |
|
|
2015
Q3 | $2.18M | Buy |
53,684
+19,650
| +58% | +$1.04M | 0.02% | 165 |
|
|
2015
Q2 | $1.77M | Buy |
34,034
+17,350
| +104% | +$863K | 0.02% | 175 |
|
|
2015
Q1 | $776K | Buy |
+16,684
| New | +$866K | 0.01% | 198 |
|
ALPS Advisors's ISEE Position: Q3 2023 in Review
ALPS Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 101,422 shares — an estimated $3.99M sold.
ALPS Advisors first reported a position in ISEE in Q1 2015 and held it in 22 quarters. The position peaked at $3.99M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- ALPS Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- ALPS Advisors sold 101,422 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.99M.
- ALPS Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 22 quarters.
- ALPS Advisors's IVERIC bio, Inc. Common Stock position peaked at $3.99M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on ALPS Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.